New York State clinical lab certification received

AI SummaryClose X

Verici Dx Plc has achieved a significant milestone by receiving clinical laboratory certification from the New York State Department of Health, enabling nationwide access to its Tutivia™ test across all 50 US states and the District of Columbia. This rigorous New York approval validates the company's laboratory operations and clinical performance, expanding access to its blood-based test which provides predictive, data-driven intelligence to classify kidney transplant patients as low or high risk of acute rejection. The Tutivia™ test aims to offer clinicians proactive indicators of rejection risk, facilitating more precise patient management, timely interventions, and potentially reducing avoidable biopsies and graft loss, particularly for complex, high-acuity patients.

Disclaimer*

Companies

Verici DX (VRCI)
UK 100

Latest directors dealings